Preclinical Safety Assessment and Mitigation Strategies in Drug Discovery
Date: 17 October 2018
Time: 15:00 - 16:00
A challenging aspect of drug discovery is the mitigation of safety risks that arise during most drug discovery optimization efforts. This webinar will highlight some of the current best practices and methods used in pharma to identify, understand and mitigate common preclinical safety risks. It will also explore proactive approaches that may help drug-hunters avoid many safety issues on the road to clinical candidate selection and first human dose.
While the focus is on medicinal chemistry methods, this webinar will benefit all scientists who participate in the cross functional execution of drug discovery programs.
This webinar will be presented by Dr Bryan Norman. Bryan is the tutor on the 2-day course: Preclinical Safety Assessment and Mitigation Strategies in Drug Discovery.